# US 2006/0155204 A1 · System and method for assessing cardiac performance through cardiac vibration monitoring

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0155204 A1
- Document ID: US20060155204A1
- Status: Published application
- Kind: A1
- Application number: 11/367,852
- Filed: 2006-03-03
- Published: 2006-07-13
- Earliest claimed: 2004-02-19
- Assignees: Cardiac Pacemakers, Inc.
- Inventors: Ramesh Wariar; Gerrard Carlson
- Web page: https://patentgrep.com/patent/US20060155204A1

## CPC

- A61B 7/04: Electric stethoscopes
- A61B 5/021: Measuring pressure in heart or blood vessels
- A61B 7/00: Instruments for auscultation
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A system and method for assessing cardiac performance through cardiac vibration monitoring is described. Cardiac vibration measures are directly collected through an implantable medical device. Cardiac events including at least one first heart sound reflected by the cardiac vibration measures are identified. The first heart sound is correlated to cardiac dimensional measures relative to performance of an intrathoracic pressure maneuver. The cardiac dimensional measures are grouped into at least one measures set corresponding to a temporal phase of the intrathoracic pressure maneuver. The at least one cardiac dimensional measures set is evaluated against a cardiac dimensional trend for the corresponding intrathoracic pressure maneuver temporal phase to represent cardiac performance.

## Claims

### Claim 1

A system for evaluating cardiac performance relative to performance of an intrathoracic pressure maneuver, comprising:
an implantable medical device to indirectly sense heart sounds by directly collecting cardiac vibration measures; and
an analysis component to evaluate cardiac functional changes to the heart sounds in response to performance of an intrathoracic pressure maneuver.

### Claim 2 (depends on 1)

A system according to claim 1, wherein ventricular preload is measured to correct S1 heart sound intensity for preload variations.

### Claim 3 (depends on 1)

A system according to claim 1, further comprising:
an evaluation component to evaluate the heart sounds to derive cardiac chamber pressure, wherein the cardiac chamber pressure comprises at least one of left ventricular ejection fraction, left ventricular end diastolic pressure, pulmonary capillary wedge pressure, pulmonary artery pressure, and an S3 index of pressure.

### Claim 4 (depends on 1)

A system according to claim 1, wherein the implantable medical device comprises at least one of a cardiac pacemaker, cardioverter defibrillator, cardiac resynchronization device, cardiovascular monitor, and therapeutic device monitoring and treating structural problems of the heart.

### Claim 5 (depends on 1)

A system according to claim 1, wherein heart sounds comprising cardiac events for at least one of intensity of a first heart sound, ratio of first heart sound energy to total energy, and ratio of first heart sound intensity to pulmonary artery pressure are determined.

### Claim 6 (depends on 1)

A system according to claim 1, wherein the intrathoracic pressure maneuver comprises at least one of a Valsalva and Müller maneuver.

### Claim 7 (depends on 1)

A system according to claim 1, further comprising:
at least one of:
an evaluation subcomponent to evaluate at least one of overdamping and underdamping cardiac impedance response relative to normative levels; and
a notification subcomponent to generate a notification responsive to the at least one of overdamping and underdamping cardiac impedance response.

### Claim 8 (depends on 1)

A system according to claim 1, wherein thoracic pressure is monitored during the intrathoracic pressure maneuver, further comprising:
an external pressure monitor to define a confined volume configured to receive at least one of a forced exhalation and a forced inhalation and to measure the thoracic pressure relative to the confined volume.

### Claim 9 (depends on 1)

A system according to claim 1, wherein the cardiac vibrations are selected from the group comprising auscultatory, sub-audible, and detectable cardiac events.

### Claim 10

A method for evaluating cardiac performance relative to performance of an intrathoracic pressure maneuver, comprising:
indirectly sensing heart sounds by directly collecting cardiac vibration measures through an implantable medical device; and
evaluating cardiac functional changes to the heart sounds in response to performance of an intrathoracic pressure maneuver.

### Claim 11 (depends on 10)

A method according to claim 10, further comprising:
measuring ventricular preload to correct S1 heart sound intensity for preload variations.

### Claim 12 (depends on 10)

A method according to claim 10, further comprising:
evaluating the heart sounds to derive cardiac chamber pressure, wherein the cardiac chamber pressure comprises at least one of left ventricular ejection fraction, left ventricular end diastolic pressure, pulmonary capillary wedge pressure, pulmonary artery pressure, and an S3 index of pressure.

### Claim 13 (depends on 10)

A method according to claim 10, wherein the medical device comprises at least one of a cardiac pacemaker, cardioverter defibrillator, cardiac resynchronization device, cardiovascular monitor, and therapeutic device monitoring and treating structural problems of the heart.

### Claim 14 (depends on 10)

A method according to claim 10, further comprising:
determining heart sounds comprising cardiac events for at least one of intensity of a first heart sound, ratio of first heart sound energy to total energy, and ratio of first heart sound intensity to pulmonary artery pressure.

### Claim 15 (depends on 10)

A method according to claim 10, wherein the intrathoracic pressure maneuver comprises at least one of a Valsalva and Müller maneuver.

### Claim 16 (depends on 10)

A method according to claim 10, further comprising:
performing at least one of:
evaluating at least one of overdamping and underdamping cardiac impedance response relative to normative levels; and
generating a notification responsive to the at least one of overdamping and underdamping cardiac impedance response.

### Claim 17 (depends on 10)

A method according to claim 10, further comprising:
monitoring thoracic pressure during the intrathoracic pressure maneuver;
defining a confined volume configured to receive at least one of a forced exhalation and a forced inhalation; and
measuring the thoracic pressure relative to the confined volume.

### Claim 18 (depends on 10)

A method according to claim 10, wherein the cardiac vibrations are selected from the group comprising auscultatory, sub-audible, and detectable cardiac events.

### Claim 19 (depends on 10)

A computer-readable storage medium holding code for performing the method of claim 10.

### Claim 20

A system for assessing cardiac performance through cardiac vibration monitoring, comprising:
an implantable medical device to directly collect cardiac vibration measures;
a correlation component to identify cardiac events comprising at least one first heart sound reflected by the cardiac vibration measures, to correlate the first heart sound to cardiac dimensional measures relative to performance of an intrathoracic pressure maneuver, and to group the cardiac dimensional measures into at least one measures set corresponding to a temporal phase of the intrathoracic pressure maneuver; and
an analysis component to evaluate the at least one cardiac dimensional measures set against a cardiac dimensional trend for the corresponding intrathoracic pressure maneuver temporal phase to represent cardiac performance.

### Claim 21 (depends on 20)

A system according to claim 20, further comprising:
an evaluation component to derive the cardiac dimensional measures by proportionately extrapolating an intensity of the first heart sound to a rate of rise of left ventricular pressure.

### Claim 22 (depends on 20)

A system according to claim 20, further comprising:
an evaluation component to determine amplitude and frequency spectrum parameters for the cardiac events for at least one of intensity of the first heart sound, ratio of first heart sound acoustic energy to total acoustic energy, and ratio of first heart sound intensity to pulmonary artery pressure.

### Claim 23 (depends on 20)

A system according to claim 20, further comprising:
an evaluation component to process the cardiac vibration measures by performing at least one of ensemble averaging, signal rectifying, and low-pass or band-pass filtering.

### Claim 24 (depends on 20)

A system according to claim 20, wherein the cardiac dimensional measures comprise at least one of cardiac stroke volume, left ventricular ejection fraction, left ventricular end diastolic dimension, and left ventricular end systolic dimension.

### Claim 25 (depends on 20)

A system according to claim 20, further comprising:
a history component to evaluate a history of cardiac performance representations; and
a trending component to recognize a trend within the history indicating at least one of cardiovascular disease absence, onset, progression, regression, and status quo.

### Claim 26 (depends on 20)

A system according to claim 20, further comprising:
a characteristic signature formed with the cardiac dimensional trends over the performance of the intrathoracic pressure maneuver; and
a comparison component to compare an overall cardiac dimensional profile comprising the at least one cardiac dimensional measures set to the characteristic signature to form a cardiac performance assessment.

### Claim 27 (depends on 20)

A system according to claim 20, further comprising:
at least one of:
a notification generated responsive to a substantially non-complying cardiac performance assessment; and
a programmer to program support to the implantable medical device.

### Claim 28 (depends on 20)

A system according to claim 20, wherein the intrathoracic pressure maneuver is selected from the group comprising Valsalva and Müller maneuvers, further comprising:
a collection component to collect the cardiac vibration measures relative to performance of the selected intrathoracic pressure maneuver.

### Claim 29

A method for assessing cardiac performance through cardiac vibration monitoring, comprising:
directly collecting cardiac vibration measures through an implantable medical device;
identifying cardiac events comprising at least one first heart sound reflected by the cardiac vibration measures;
correlating the first heart sound to cardiac dimensional measures relative to performance of an intrathoracic pressure maneuver;
grouping the cardiac dimensional measures into at least one measures set corresponding to a temporal phase of the intrathoracic pressure maneuver; and
evaluating the at least one cardiac dimensional measures set against a cardiac dimensional trend for the corresponding intrathoracic pressure maneuver temporal phase to represent cardiac performance.

### Claim 30 (depends on 29)

A method according to claim 29, further comprising:
deriving the cardiac dimensional measures by proportionately extrapolating an intensity of the first heart sound to a rate of rise of left ventricular pressure.

### Claim 31 (depends on 29)

A method according to claim 29, further comprising:
determining amplitude and frequency spectrum parameters for the cardiac events for at least one of intensity of the first heart sound, ratio of first heart sound acoustic energy to total acoustic energy, and ratio of first heart sound intensity to pulmonary artery pressure.

### Claim 32 (depends on 29)

A method according to claim 29, further comprising:
processing the cardiac vibration measures by performing at least one of ensemble averaging, signal rectifying, and low-pass or band-pass filtering.

### Claim 33 (depends on 29)

A method according to claim 29, wherein the cardiac dimensional measures comprise at least one of cardiac stroke volume, left ventricular ejection fraction, left ventricular end diastolic dimension, and left ventricular end systolic dimension.

### Claim 34 (depends on 29)

A method according to claim 29, further comprising:
evaluating a history of cardiac performance representations; and
recognizing a trend within the history indicating at least one of cardiovascular disease absence, onset, progression, regression, and status quo.

### Claim 35 (depends on 29)

A method according to claim 29, further comprising:
forming a characteristic signature with the cardiac dimensional trends over the performance of the intrathoracic pressure maneuver; and
comparing an overall cardiac dimensional profile comprising the at least one cardiac dimensional measures set to the characteristic signature to form a cardiac performance assessment.

### Claim 36 (depends on 29)

A method according to claim 29, further comprising:
performing at least one of:
generating a notification responsive to a substantially non-complying cardiac performance assessment; and
providing programming support to the implantable medical device.

### Claim 37 (depends on 29)

A method according to claim 29, further comprising:
selecting the intrathoracic pressure maneuver from the group comprising Valsalva and Müller maneuvers; and
collecting the cardiac vibration measures relative to performance of the selected intrathoracic pressure maneuver.

### Claim 38 (depends on 29)

A computer-readable storage medium holding code for performing the method of claim 29.
